FDA Weighing Approval of SECOND Booster Shot

The FDA signaled their intent to approve a second COVID-19 booster. 

Alison Hunt, a spokesperson for the FDA, said the administration is “continually looking at the emerging data on the pandemic and variants,” per BizPacReview. 

“As more data becomes available about the safety and effectiveness of COVID-19 vaccines,” Hunt said, “including the use of a booster dose, we will continue to evaluate the rapidly changing science and keep the public informed.” 

Fauci suggested it would be best to give a second booster, if needed, in the fall or winter. 

“Any determination that additional booster doses are needed will be based on data available to the agency,” Hunt said. 

In a January interview, Pfizer CEO Albert Bourla said that he hopes to have a yearly COVID-19 vaccine. 

“What I’m hoping [is] we will have a vaccine that you will have to do once a year,” he said. “Once a year it is easier to convince people to do it.” 

Last week, Project Veritas released a bombshell exposé showing FDA Executive Officer of Countermeasures Initiative Christopher Cole discussing the inevitability of further vaccine approvals and annual shots. 

“If [Big Pharma] can get every person required [to get] an annual vaccine, that is a recurring return of money going into their company,” he said. 

“So, you’ll have to get an annual shot,” he continued. “I mean, it hasn’t been formally announced yet ‘cause they don’t want to rile everyone up…I think what’s going to happen is it’s going to be a gradual thing.”